ArticlePloS one2019

IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway.

Ku-Chung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.